885 filings
Page 6 of 45
4
Gaston Picchio
20 Jan 22
Arbutus Biopharma / Gaston Picchio ownership change
5:54pm
4
McElhaugh Michael J.
20 Jan 22
Arbutus Biopharma / Michael J. McElhaugh ownership change
5:53pm
D
ABUS
Arbutus Biopharma Corp
30 Dec 21
$15M in equity, sold $15M, 1 investor
11:26am
8-K
ABUS
Arbutus Biopharma Corp
14 Dec 21
Other Events
7:31am
8-K
ABUS
Arbutus Biopharma Corp
13 Dec 21
Entry into a Material Definitive Agreement
7:38am
8-K
ABUS
Arbutus Biopharma Corp
10 Dec 21
Entry into a Material Definitive Agreement
7:30am
8-K
ABUS
Arbutus Biopharma Corp
7 Dec 21
Arbutus Biopharma, X-Chem and Proteros biostructures Achieve First Milestone Under COVID-19 Discovery Research and License Agreement
7:31am
4
Michael J. Sofia
3 Dec 21
Arbutus Biopharma / Michael J. Sofia ownership change
4:02pm
8-K
ABUS
Arbutus Biopharma Corp
1 Dec 21
Other Events
12:50pm
EFFECT
ABUS
Arbutus Biopharma Corp
19 Nov 21
Notice of effectiveness
12:15am
UPLOAD
ABUS
Arbutus Biopharma Corp
16 Nov 21
Letter from SEC
12:00am
CORRESP
ABUS
Arbutus Biopharma Corp
16 Nov 21
Correspondence with SEC
12:00am
8-K
ABUS
Arbutus Biopharma Corp
12 Nov 21
Arbutus Biopharma Appoints Tram Tran, M.D. to its Board of Directors
7:30am
4
Tram Tran
12 Nov 21
Arbutus Biopharma / Tram Tran ownership change
6:22am
3
Tram Tran
12 Nov 21
Arbutus Biopharma / Tram Tran ownership change
6:17am
8-K
ABUS
Arbutus Biopharma Corp
12 Nov 21
Arbutus’ Lead Compound AB-729 Continues to be Safe and Effective at Reducing HBsAg in Patients with Chronic Hepatitis B
6:00am
S-3
ABUS
Arbutus Biopharma Corp
Shelf registration
4 Nov 21
5:05pm
10-Q
2021 Q3
ABUS
Arbutus Biopharma Corp
Quarterly report
4 Nov 21
4:07pm
8-K
ABUS
Arbutus Biopharma Corp
4 Nov 21
Arbutus Reports Third Quarter 2021 Financial Results and Provides Corporate Update
7:31am
4
ROIV
Roivant Sciences Ltd
20 Oct 21
Change in insider ownership
5:14pm